Advances in Pharmacological Therapy of Benign Tracheal Stenosis: A Meta-Analysis of Preclinical Studies.

IF 1.9 4区 医学 Q2 OTORHINOLARYNGOLOGY
Laryngoscope Investigative Otolaryngology Pub Date : 2026-08-04 eCollection Date: 2026-08-01 DOI:10.1002/lio2.70497
Dengyuan Li, Jie Zeng, Rufang Li, Rong Wang, Danxiong Sun
{"title":"Advances in Pharmacological Therapy of Benign Tracheal Stenosis: A Meta-Analysis of Preclinical Studies.","authors":"Dengyuan Li, Jie Zeng, Rufang Li, Rong Wang, Danxiong Sun","doi":"10.1002/lio2.70497","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Benign tracheal stenosis, characterized by granulation hyperplasia, is a rare and serious disease threatening human health. Interventional bronchoscopy demonstrates limited therapeutic efficacy and poses a risk of re-injury to the airway. The objective of this meta-analysis is to evaluate the efficacy of pharmacological therapy in preclinical models of tracheal stenosis.</p><p><strong>Method: </strong>We conducted an extensive literature search across PubMed, EMBASE, Web of Science, and Cochrane Library from inception to January 31, 2024. Studies evaluated the efficacy of various pharmacological agents in treating tracheal stenosis. The SYRCLE bias risk tool was utilized to evaluate potential bias, and the GRADE approach was used to assess the quality of evidence for each outcome. Primary outcomes included the stenosis index (SI) and the degree of tracheal stenosis (SD). Secondary outcomes comprised additional indicators relevant to evaluation of tracheal stenosis, such as the fibrosis indexes, the ratio of the lamina propria thickness to the cartilage (LCR), and the severity of inflammation. Meta-analysis was conducted via Cochrane Collaboration Review Manager (version 5.4).</p><p><strong>Results: </strong>A total of 7554 studies related to pharmacological therapies for benign airway stenosis were reviewed, of which 34 articles met inclusion criteria for this meta-analysis following study selection. Of these, five studies evaluated SI, 17 studies evaluated SD, and six studies evaluated the fibrosis indexes. Compared to the control group, pharmacological therapy was associated with a significant reduction in SI (weighted mean difference (WMD) -0.21, 95% CI: -0.33 to -0.10, <i>p</i> < 0.001, <i>I</i> <sup>2</sup> = 82%), SD (WMD = -0.26; 95% CI: -0.34 to -0.18; <i>p</i> < 0.001, <i>I</i> <sup>2</sup> = 93%), and the fibrosis indexes (WMD = -3.15; 95% CI: -4.4 to -1.9; <i>p</i> < 0.001, <i>I</i> <sup>2</sup> = 82%).</p><p><strong>Conclusion: </strong>Various pharmacological agents exhibited different efficacies in alleviating tracheal stenosis symptoms. These findings provide valuable insights into prospective therapeutic strategies.</p>","PeriodicalId":48529,"journal":{"name":"Laryngoscope Investigative Otolaryngology","volume":"11 4","pages":"e70497"},"PeriodicalIF":1.9000,"publicationDate":"2026-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13436614/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Laryngoscope Investigative Otolaryngology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/lio2.70497","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/8/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Benign tracheal stenosis, characterized by granulation hyperplasia, is a rare and serious disease threatening human health. Interventional bronchoscopy demonstrates limited therapeutic efficacy and poses a risk of re-injury to the airway. The objective of this meta-analysis is to evaluate the efficacy of pharmacological therapy in preclinical models of tracheal stenosis.

Method: We conducted an extensive literature search across PubMed, EMBASE, Web of Science, and Cochrane Library from inception to January 31, 2024. Studies evaluated the efficacy of various pharmacological agents in treating tracheal stenosis. The SYRCLE bias risk tool was utilized to evaluate potential bias, and the GRADE approach was used to assess the quality of evidence for each outcome. Primary outcomes included the stenosis index (SI) and the degree of tracheal stenosis (SD). Secondary outcomes comprised additional indicators relevant to evaluation of tracheal stenosis, such as the fibrosis indexes, the ratio of the lamina propria thickness to the cartilage (LCR), and the severity of inflammation. Meta-analysis was conducted via Cochrane Collaboration Review Manager (version 5.4).

Results: A total of 7554 studies related to pharmacological therapies for benign airway stenosis were reviewed, of which 34 articles met inclusion criteria for this meta-analysis following study selection. Of these, five studies evaluated SI, 17 studies evaluated SD, and six studies evaluated the fibrosis indexes. Compared to the control group, pharmacological therapy was associated with a significant reduction in SI (weighted mean difference (WMD) -0.21, 95% CI: -0.33 to -0.10, p < 0.001, I 2 = 82%), SD (WMD = -0.26; 95% CI: -0.34 to -0.18; p < 0.001, I 2 = 93%), and the fibrosis indexes (WMD = -3.15; 95% CI: -4.4 to -1.9; p < 0.001, I 2 = 82%).

Conclusion: Various pharmacological agents exhibited different efficacies in alleviating tracheal stenosis symptoms. These findings provide valuable insights into prospective therapeutic strategies.

良性气管狭窄的药物治疗进展:临床前研究荟萃分析。
背景:以肉芽增生为特征的良性气管狭窄是一种罕见且严重威胁人类健康的疾病。介入支气管镜检查显示治疗效果有限,并有气道再损伤的风险。本荟萃分析的目的是评估药物治疗在临床前气管狭窄模型中的疗效。方法:我们在PubMed, EMBASE, Web of Science和Cochrane Library中进行了广泛的文献检索,检索时间从成立到2024年1月31日。研究评估了各种药物治疗气管狭窄的疗效。使用sycle偏倚风险工具评估潜在偏倚,使用GRADE方法评估每个结局的证据质量。主要结局包括狭窄指数(SI)和气管狭窄程度(SD)。次要结局包括与气管狭窄评估相关的其他指标,如纤维化指标、固有层厚度与软骨(LCR)的比例以及炎症的严重程度。meta分析通过Cochrane Collaboration Review Manager (version 5.4)进行。结果:共回顾了7554项与良性气道狭窄药物治疗相关的研究,其中34篇文章在研究选择后符合本荟萃分析的纳入标准。其中,5项研究评估SI, 17项研究评估SD, 6项研究评估纤维化指标。与对照组相比,药物治疗与SI(加权平均差(WMD) -0.21, 95% CI: -0.33至-0.10,p I 2 = 82%)、SD (WMD = -0.26, 95% CI: -0.34至-0.18,p I 2 = 93%)和纤维化指数(WMD = -3.15, 95% CI: -4.4至-1.9,p I 2 = 82%)显著降低相关。结论:不同药物对缓解气管狭窄症状的疗效不同。这些发现为未来的治疗策略提供了有价值的见解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.00
自引率
0.00%
发文量
245
审稿时长
11 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书